Petmed Express INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NASDAQ
PetMed Express, Inc. announced its annual report for the fiscal year ended March 31, 2026, detailing a substantial decrease in net sales and a significant increase in net loss, alongside ongoing efforts to remediate material weaknesses in internal controls.
NASDAQ
PetMed Express, Inc. has filed a comprehensive annual report on Form 10-K, restating prior financial statements due to accounting errors and announcing significant leadership changes following an internal audit committee investigation.
NASDAQ
PetMed Express, Inc.'s 2024 annual report reveals a year of strategic transitions, including the acquisition of PetCareRx, alongside financial headwinds and internal control weaknesses.
NASDAQ
PetMed Express has restated its financial statements for fiscal years 2021 through 2023 due to accounting errors primarily related to sales tax liabilities.